Filing Details
- Accession Number:
- 0001567619-20-012534
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-24 16:55:07
- Reporting Period:
- 2020-06-22
- Accepted Time:
- 2020-06-24 16:55:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1512762 | Coherus Biosciences Inc. | CHRS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1410289 | T Mary Szela | Coherus Biosciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City CA 94065 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2020-06-22 | 14,997 | $2.50 | 14,997 | No | 4 | M | Direct | |
| Common Stock, $0.0001 Par Value | Acquisiton | 2020-06-22 | 20,000 | $10.05 | 34,997 | No | 4 | M | Direct | |
| Common Stock, $0.0001 Par Value | Acquisiton | 2020-06-22 | 20,000 | $12.37 | 54,997 | No | 4 | M | Direct | |
| Common Stock, $0.0001 Par Value | Disposition | 2020-06-22 | 54,997 | $17.58 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-22 | 14,997 | $0.00 | 14,997 | $2.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-22 | 20,000 | $0.00 | 20,000 | $10.05 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-22 | 20,000 | $0.00 | 20,000 | $12.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-06-30 | No | 4 | M | Direct | |
| 0 | 2028-02-01 | No | 4 | M | Direct | |
| 0 | 2029-01-11 | No | 4 | M | Direct |
Footnotes
- The transaction was executed in multiple trades in prices ranging from $17.43 to $17.71, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- All of the shares underlying this option are vested and exercisable as of the date hereof.
Billionaire Hedge Funds
